SCHEMBL19068172

SCHEMBL19068172

CCC(=O)c1cn(S(C)(=O)=O)c2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.56
▸ HTR3A P46098 4/20 0.50
▸ LMNA P02545 3/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ HTR6 P50406 1/20 0.49
▸ TSHR P16473 1/20 0.48
▸ MEN1 O00255 4/20 0.47
▸ PLK1 P53350 1/20 0.47
▸ MITF O75030 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ POLB P06746 1/20 0.46
▸ CNR1 P21554 1/20 0.45
▸ AKR1C3 P42330 1/20 0.45
▸ AKR1C1 Q04828 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19068164 0.85 HTR3A (0.48) KMT2AL3MBTL1HTR3ALMNASMN1; SMN2
SCHEMBL27622290 0.84 LMNA (0.72) KMT2AL3MBTL1LMNASMN1; SMN2HTR6
SCHEMBL17176310 0.83 SMN1; SMN2 (0.70) KMT2AL3MBTL1HTR3ALMNASMN1; SMN2
SCHEMBL6674814 0.83 AKR1C3 (0.62) KMT2AHTR3ALMNASMN1; SMN2HTR6
SCHEMBL6672345 0.81 FABP4 (0.55) KMT2AHTR3ALMNASMN1; SMN2HTR6
SCHEMBL19969859 0.80 HTR3A (0.54) HTR3AHTR6CNR1
SCHEMBL17170611 0.79 ALDH1A1 (0.56) KMT2AL3MBTL1HTR3ALMNASMN1; SMN2
SCHEMBL4106159 0.78 KMT2A (0.73) KMT2AL3MBTL1HTR3ALMNASMN1; SMN2
SCHEMBL16979075 0.76 KMT2A (0.75) KMT2AL3MBTL1LMNASMN1; SMN2TSHR
SCHEMBL22289917 0.75 HTR3A (0.56) KMT2AHTR3ALMNASMN1; SMN2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9695195-B2 5-HT3 receptor antagonists TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-07-04 — — US disclosed
Send feedback